1 n, or disease-free survival in patients with papillary cancer.

2 ents enrolled between 2007 and 2010; 92% had papillary cancer.

3 ntly due to the increased detection of small papillary cancers.

4 s had benign and 71 had malignant tumors (58 papillary cancers, 10 follicular cancers, 1 Hurthle cell

5                   Histopathology included 88 papillary cancers, 7 follicular cancers, and 4 Hurthle c

6 dine-131 was given to 85.4% of patients with papillary cancer and 79.3% of patients with follicular c

7  improvement in progression in patients with papillary cancer and improvement in progression and dise

8   This novel isoform was present in both the papillary cancers and contralateral tissues.

9                    Several isoforms found in papillary cancers are not detectable in histologically n

10 al Akt were identified in follicular but not papillary cancers compared with normal tissue.

11                                              Papillary cancers in younger children were histologicall

12 pillary thyroid cancers presenting as occult papillary cancers (<1 cm) and as a dominant nodule had s

13 s (i.e., low grade clear cell carcinomas and papillary cancers), normal cadherin-6 expression was pre

14 re reported for all participants, those with papillary cancer only, and women only.

15                                      Thyroid papillary cancers (PTCs) are associated with activating

16                             In patients with papillary cancer, radioiodine therapy was associated wit

17           In addition to well-differentiated papillary cancer, STRN-ALK was found with a higher preva

18          Therefore, as with hereditary renal papillary cancer, the mutant Met allele may also be sele